Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Overall survival by race in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide.

(2019) Megan Ann McNamara et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer statistics for African Americans, 2019

(2019) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer

(2019) Celestia S. Higano et al.   CANCER

Racial Discrepancies in Overall Survival among Men Treated with Radium-223

(2019) Hanson Zhao et al.   JOURNAL OF UROLOGY

Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database

(2018) Adriana C. Vidal et al.   CANCER CAUSES & CONTROL

Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association With Overall Survival

(2018) Emmanuel S. Antonarakis et al.   CLINICAL CANCER RESEARCH

Whole Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naive, High-Risk Prostate Cancer

(2018) Weerachai Jaratlerdsiri et al.   CANCER RESEARCH

Cerebrovascular event (CVE) outcome and overall survival (OS) in patients (pts) treated with sipuleucel-T (sip-T) for metastatic castration-resistant prostate cancer (mCRPC): results from the PROCEED registry.

(2018) Celestia S. Higano et al.   JOURNAL OF CLINICAL ONCOLOGY

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel

(2018) Susan Halabi et al.   JOURNAL OF CLINICAL ONCOLOGY

Racial disparities in prostate cancer a molecular perspective

(2017) Arun Bhardwaj   Frontiers in Bioscience-Landmark

Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer

(2017) Bi-Dar Wang et al.   Nature Communications

Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations

(2017) Franklin W. Huang et al.   Cancer Discovery

African-American Prostate Cancer Disparities

(2017) Zachary L. Smith et al.   Current Urology Reports

African American Participation in Oncology Clinical Trials—Focus on Prostate Cancer: Implications, Barriers, and Potential Solutions

(2016) Chiledum Ahaghotu et al.   Clinical Genitourinary Cancer

Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood

(2016) Raj Kurupati et al.   Oncotarget

Disparities in Castration-Resistant Prostate Cancer Trials

(2015) Daniel E. Spratt et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer

(2015) Kosj Yamoah et al.   JOURNAL OF CLINICAL ONCOLOGY

Trans-ethnic meta-analysis of white blood cell phenotypes

(2014) M. F. Keller et al.   HUMAN MOLECULAR GENETICS

Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men

(2013) I. J. Powell et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes

(2013) Matthew A. Kinseth et al.   INTERNATIONAL JOURNAL OF CANCER

Influence of Race/Ethnic Differences in Pre-Transplantation Panel Reactive Antibody on Outcomes in Heart Transplant Recipients

(2013) Alanna A. Morris et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial

(2013) Paul F. Schellhammer et al.   UROLOGY

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

(2012) Nadeem A. Sheikh et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Racial differences in B cell receptor signaling pathway activation

(2012) Diane M Longo et al.   Journal of Translational Medicine

953 SIPULEUCEL-T IN AFRICAN AMERICANS: A SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS OF SIPULEUCEL-T IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER

(2012) David G. McLeod et al.   JOURNAL OF UROLOGY

Race-specific WBC and neutrophil count reference intervals

(2010) E.-M. LIM et al.   International Journal of Laboratory Hematology

Evidence Supports a Faster Growth Rate and/or Earlier Transformation to Clinically Significant Prostate Cancer in Black Than in White American Men, and Influences Racial Progression and Mortality Disparity

(2010) Isaac J. Powell et al.   JOURNAL OF UROLOGY

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer

(2010) Ganna Chornokur et al.   PROSTATE

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men

(2008) T. A. Wallace et al.   CANCER RESEARCH